Uterine leiomyomata and endometrial proliferation in postmenopausal women treated with the anti-oestrogen tamoxifen

A H Ugwumadu, Austin Ugwumadu, Kate Harding, K Harding
European Journal of Obstetrics & Gynecology and Reproductive Biology · 1994 · vol. 54(2) , pp. 153–156 · doi:10.1016/0028-2243(94)90258-5 · PMID:8070603 · W2016587661
Case report OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study investigated the effects of tamoxifen on uterine leiomyomata and endometrial proliferation in postmenopausal women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Two cases of fibroid growth and endometrial proliferation in postmenopausal women on tamoxifen (anti-oestrogen) therapy for breast cancer are described. Oestrogen in association with growth factors may control fibroid growth and differentiation. The possible mechanisms and consequences of tamoxifen-induced fibroid growth are discussed. Oestrogen responsive tissues demonstrate a differential and contrasting response to tamoxifen and caution should be exercised in the expansion of its clinical application. Women on long-term tamoxifen therapy may benefit from ultrasound surveillance of their uterus and endometrium, with biopsy in suspicious cases, as there is a paucity of data on malignant transformation of these benign lesions induced by tamoxifen therapy.

My notes (saved in your browser only)

MeSH descriptors

Breast Neoplasms Endometrial Hyperplasia Leiomyoma Postmenopause Tamoxifen Uterine Neoplasms Breast Neoplasms Endometrial Hyperplasia Endometrial Hyperplasia Female Humans Leiomyoma Leiomyoma Middle Aged Tamoxifen Uterine Neoplasms Uterine Neoplasms

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

Cited by (3)

References (36)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:59:20.378211+00:00
License: CC0 · commercial use OK